The role of EPCR-FVIIa in the pathogenesis and treatment of hemophilic arthropathy

Awarded/Presented

2020 2022

Tags

Judith Graham Pool Postdoctoral Research Fellowship

EPCR-FVIIa/Antropathy

Researchers

Jhansi Magisetty

From University of Texas Health Science Center at Tyler (UTHSCT). Dr. Magisetty completed Ph.D. doctoral training on the evaluation of FVIIa-EPCR interactions in the management of hemophilic arthropathy and is enthusiastic looking forward to the postdoctoral training on the “Role of EPCR-FVIIa anti-inflammatory signaling in the pathogenesis and treatment of hemophilic arthropathy”.